The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
Open accessAbstract
Purpose: The role of adjuvant chemotherapy (AC) or induction chemotherapy (IC) in the treatment of locally advanced nasopharyngeal carcinoma is controversial. The individual patient data from the Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma database were used to compare all available treatments. Methods: All randomized trials of radiotherapy (RT) with or without chemotherapy in nonmetastatic nasopharyngeal carcinoma were considered. Overall, 20 trials and 5,144 patients were included. Treatments were grouped into seven categories: RT alone (RT), IC followed by RT (IC-RT), RT followed by AC (RT-AC), IC followed by RT followed by AC (IC-RT-AC), concomitant chemoradiotherapy (CRT), IC followed by CRT (IC-CRT), and CRT followed by AC (CRT-AC). P-score was used to rank the treatments. Fixed- and random-effects frequentist network meta-analysis models were applied. Results: The three treatments with the highest probability of benefit on overall survival (OS) were CRT-AC, followed by CRT and IC-CRT, with respective hazard ratios (HRs [95% CIs]) compared with RT alone of 0.65 (0.56 to 0.75), 0.77 (0.64 to 0.92), and 0.81 (0.63 to 1.04). HRs (95% CIs) of CRT-AC compared with CRT for OS, progression-free survival (PFS), locoregional control, and distant control (DC) were, respectively, 0.85 (0.68 to 1.05), 0.81 (0.66 to 0.98), 0.70 (0.48 to 1.02), and 0.87 (0.61 to 1.25). IC-CRT ranked second for PFS and the best for DC. CRT never ranked first. HRs of CRT compared with IC-CRT for OS, PFS, locoregional control, and DC were, respectively, 0.95 (0.72 to 1.25), 1.13 (0.88 to 1.46), 1.05 (0.70 to 1.59), and 1.55 (0.94 to 2.56). Regimens with more chemotherapy were associated with increased risk of acute toxicity. Conclusion: The addition of AC to CRT achieved the highest survival benefit and consistent improvement for all end points. The addition of IC to CRT achieved the highest effect on DC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Salanti, G., Ades, A. E., & Ioannidis, J. P. A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.016 · Cited by 3,766
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
Graphical tools for network meta-analysis in STATA
Chaimani, A., Higgins, J. P. T., Mavridis, D., Spyridonos, P., & Salanti, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076654 · Cited by 2,473
Al-Sarraf, M., LeBlanc, M., Giri, P. G., Fu, K. K., Cooper, J., Vuong, T., Forastiere, A. A., Adams, G., Sakr, W. A., Schuller, D. E., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1310 · Cited by 2,222
Combination of direct and indirect evidence in mixed treatment comparisons
Lu, G., & Ades, A. E. (2004) · Statistics in Medicine · doi:10.1002/sim.1875 · Cited by 2,166
Ranking treatments in frequentist network meta-analysis works without resampling methods
Rücker, G., & Schwarzer, G. (2015) · BMC Medical Research Methodology · doi:10.1186/s12874-015-0060-8 · Cited by 1,732
Biomedical research: increasing value, reducing waste.
Macleod, M. R., Michie, S., Roberts, I., Dirnagl, U., Chalmers, I., Ioannidis, J. P. A., Salman, R. A.-S., Chan, A.-W., & Glasziou, P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62329-6 · Cited by 1,003
Self-citationMeta-analysis of the literature or of individual patient data: is there a difference?
Stewart, L. A., & Parmar, M. K. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)93004-k · Cited by 769
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Blanchard, P., Lee, A., Marguet, S., Leclercq, J., Ng, W. T., Ma, J., Chan, A. T. C., Huang, P.-Y., Benhamou, E., Zhu, G., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70126-9 · Cited by 755
Self-citationNetwork meta‐analysis, electrical networks and graph theory
Rücker, G. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1058 · Cited by 730
Wee, J., Tan, E. H., Tai, B. C., Wong, H. B., Leong, S. S., Tan, T., Chua, E. T., Yang, E., Lee, K. M., Fong, K. W., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.790 · Cited by 650
Chen, L., Hu, C.-S., Chen, X.-Z., Hu, G.-Q., Cheng, Z.-B., Sun, Y., Li, W.-X., Chen, Y.-Y., Xie, F.-Y., Liang, S.-B., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70320-5 · Cited by 558
Self-citationMultiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer
Mauri, D., Polyzos, N. P., Salanti, G., Pavlidis, N., & Ioannidis, J. P. A. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn414 · Cited by 523
Hui, E. P., Ma, B. B., Leung, S. F., King, A. D., Mo, F., Kam, M. K., Yu, B. K., Chiu, S. K., Kwan, W. H., Ho, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1545 · Cited by 523
Self-citationGetReal in network meta-analysis: a review of the methodology
Efthimiou, O., Debray, T. P. A., van Valkenhoef, G., Trelle, S., Panayidou, K., Moons, K. G. M., Reitsma, J. B., Shang, A., Salanti, G., & on behalf of GetReal Methods Review Group (2016) · Research Synthesis Methods · doi:10.1002/jrsm.1195 · Cited by 401
Self-citationNCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
Adelstein, D., Gillison, M. L., Pfister, D. G., Spencer, S., Adkins, D., Brizel, D. M., Burtness, B., Busse, P. M., Caudell, J. J., Cmelak, A. J., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0101 · Cited by 371
Chen, Q.-Y., Wen, Y.-F., Guo, L., Liu, H., Huang, P.-Y., Mo, H.-Y., Li, N.-W., Xiang, Y.-Q., Luo, D.-H., Qiu, F., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr432 · Cited by 339
Self-citation(1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)80007-1 · Cited by 338
Lee, A. W. M., Tung, S. Y., Chua, D. T. T., Ngan, R. K. C., Chappell, R., Tung, R., Siu, L., Ng, W. T., Sze, W. K., Au, G. K. H., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq258 · Cited by 318
Self-citationFountzilas, G., Ciuleanu, E., Bobos, M., Kalogera-Fountzila, A., Eleftheraki, A. G., Karayannopoulou, G., Zaramboukas, T., Nikolaou, A., Markou, K., Resiga, L., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr116 · Cited by 249
Self-citationChen, Y., Sun, Y., Liang, S., Zong, J., Li, W., Chen, M., Chen, L., Mao, Y., Tang, L., Guo, Y., et al. (2013) · Cancer · doi:10.1002/cncr.28049 · Cited by 166
Self-citationWei, Y., Royston, P. J., Tierney, J. F., & Parmar, M. (2015) · Statistics in Medicine · doi:10.1002/sim.6556 · Cited by 92
Beyene, J., Kibret, T., & Richer, D. (2014) · Clinical Epidemiology · doi:10.2147/clep.s69660 · Cited by 81
Yan, M., Kumachev, A., Siu, L. L., & Chan, K. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.04.027 · Cited by 74
Chen, Y., Guo, R., Liu, N., Liu, X., Mao, Y., Tang, L., Zhou, G., Lin, A.-H., Sun, Y. H., & Ma, J. (2015) · Journal of Cancer · doi:10.7150/jca.11814 · Cited by 73
Self-citationBlanchard, P., Hill, C., Guihenneuc‐Jouyaux, C., Baey, C., Bourhis, J., & Pignon, J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.10.016 · Cited by 71
Self-citationYu, H., Gu, D., Gao, X., He, X., & Bian, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s96983 · Cited by 19
Cited by
Chen, Y.-P., Chan, A. T. C., Le, Q.-T., Blanchard, P., Sun, Y., & Ma, J. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30956-0 · Cited by 3,077
Self-citationNasopharyngeal carcinoma: an evolving paradigm
Wong, K. C. W., Hui, E. P., Lo, K.-W., Lam, W. K. J., Johnson, D., Li, L., Tao, Q., Chan, K. C. A., To, K.-F., King, A. D., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00524-x · Cited by 546
Self-citationBossi, P., Chan, A. T., Licitra, L., Trama, A., Orlandi, E., Hui, E. P., Halámková, J., Mattheis, S., Baujat, B., Hardillo, J., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.12.007 · Cited by 447
Self-citationTang, L., Chen, Y., Chen, C., Chen, M., Chen, N., Chen, X., Du, X., Fang, W., Feng, M., Gao, J., et al. (2021) · Cancer Communications · doi:10.1002/cac2.12218 · Cited by 413
Self-citationChen, Y.-P., Ismaila, N., Chua, M. L. K., Colevas, A. D., Haddad, R., Huang, S. H., Wee, J. T. S., Whitley, A. C., Yi, J.-L., Yom, S. S., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03237 · Cited by 390
Self-citation
Metadata
- Authors
- Ribassin-Majed, L., Marguet, S., Lee, A. W. M., Ng, W. T., Ma, J., Chan, A. T. C., Huang, P.-Y., Zhu, G., Chua, D. T. T., Chen, Y., Mai, H.-Q., Kwong, D. L. W., Cheah, S.-L., Moon, J., Tung, Y., Chi, K.-H., Fountzilas, G., Bourhis, J., Pignon, J. P., Blanchard, P., & on behalf of the Meta-Analysis of Chemotherapy in Nasopharyngeal Collaborative Group
- Venue
- Journal of Clinical Oncology
- Published
- 2017-02-10
- Volume
- 35
- Issue
- 5
- Pages
- 498-505
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2559861554
- Cited by
- 352
- References
- 30
- FWCI
- 30.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.